Arthritic Therapeutic Market Report 2024 (Global Edition)

Global Arthritic Therapeutic Market Report 2024 Market Size Split by Product Type (Non-steroidal Anti-inflammatory Drugs (NSAIDs), Disease Modified Anti-rheumatoid Drugs (DMARDs), Biologics, Others), ...

Arthritic Therapeutic Market Report Description

We have various report editions of Arthritic Therapeutic Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Arthritic Therapeutic Market Insights Video

Competitive Landscape of the Arthritic Therapeutic Market

The market is dominated by a few prominent actors who have made significant contributions to the development of novel remedies. Biologics occupy a dominant position in the market, which is divided into biologics and non-biologics. Some emerging market participants in the market include Regeneron Pharmaceuticals Inc. and UCB S.A. These organizations prioritize the acquisition of funding from government entities and healthcare organizations, which is achieved through the introduction of innovative products that capitalize on unexplored opportunities.

July 2020: TREMFYA (guselkumab) has been approved by the U.S. Food and Drug Administration (FDA) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease that is characterized by skin inflammation and excruciating joints, according to the Janssen Pharmaceutical Companies of Johnson & Johnson. (Source: https://www.jnj.com/media-center/press-releases/tremfya-guselkumab-approved-by-u-s-food-and-drug-administration-as-the-first-selective-interleukin-il-23-inhibitor-for-active-psoriatic-arthritis) October 2023: Alfasigma S.p.A. has reached an agreement to acquire the Jyseleca business from Galapagos, a multinational biotechnology company based in Belgium that specializes in the development of innovative immunology and oncology treatments. (Source: https://www.glpg.com/press-releases/galapagos-signs-agreement-to-transfer-jyseleca-business-to-alfasigma/)

Top Companies Market Share in Arthritic Therapeutic Industry: (In no particular order of Rank)

• Merck & Co.
• Inc.
• Pfizer Inc.
• Viatris Inc.
• LEO Pharma
• Jhonson & Jhonson
• Amgen Inc.
• Novartis AG
• AbbVie Inc.
• Bausch Health (Storz Opthalmic Instrument)
• Celltrion Inc.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Arthritic Therapeutic Market

Which Region Dominates the Arthritic Therapeutic Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue. Regulatory changes, demographic shifts, advancements in medical research, and an increasing emphasis on personalized healthcare are all contributing to the regional market's ongoing growth and evolution. The demand for rheumatoid arthritis therapeutics is significantly influenced by the aging population in the region.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the Arthritic Therapeutic market as a result of factors such as the aging population, evolving lifestyles, and the rise in awareness that has led to early diagnosis. The increasing prevalence of RA has resulted in a heightened demand for affordable and effective remedies, which has prompted healthcare providers and policymakers to concentrate on the enhancement of RA care and management.

The current report Scope analyzes Arthritic Therapeutic Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Arthritic Therapeutic Market

According to Cognitive Market Research, the global Arthritic Therapeutic market size was estimated at USD 81254.2 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 32501.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Arthritic Therapeutic market with a market size of USD 25643.83 million in 2024 and is believed to grow at a CAGR of 4.0% during the projected period. The nation's growing releases of products, approvals of such products, and encouraging clinical trials.
• The Canada Arthritic Therapeutic market had a market share of USD 3900.20 million in 2024 and is believed to grow at a CAGR of 5.0% during the projected period. Canada's increasing critical need for therapeutic solutions that are effective.
• The Mexico Arthritic Therapeutic market is believed to see growth at a CAGR of 4.7% during the projected period, with a market size of USD 2957.65 million in 2024.

Europe Arthritic Therapeutic Market

According to Cognitive Market Research, the global Arthritic Therapeutic market size was estimated at USD 81254.2 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 24376.26 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.5% from 2024 to 2031.

• The United Kingdom Arthritic Therapeutic market had a market share of USD 4095.21 million in 2024 and is believed to grow at a CAGR of 5.3% during the projected period. In the UK, Arthritic Therapeutic sales see an upswing due to the growing advancements and innovations in the region.
• The France Arthritic Therapeutic market is believed to see growth at a CAGR of 3.7% during the projected period, with a market size of USD 2242.62 million in 2024.
• According to Cognitive Market Research, the German Arthritic Therapeutic market size was valued at USD 4826.50 million in 2024 and is believed to grow at a CAGR of 4.7% during the projected period. In Germany, Arthritic Therapeutic surged due to the growing long-term observational investigations and comprehensive research initiatives.
• The Italy Arthritic Therapeutic market is believed to see growth at a CAGR of 3.9% during the projected period, with a market size of USD 2096.36 million in 2024.
• The Russia Arthritic Therapeutic market is believed to see growth at a CAGR of 3.5% during the projected period, with a market size of USD 3778.32 million in 2024.
• The Spain Arthritic Therapeutic market is believed to see growth at a CAGR of 3.6% during the projected period with a market size of USD 1998.85 million in 2024
• The Luxembourg Arthritic Therapeutic market is believed to see growth at a CAGR of 4.6% during the projected period, with a market size of USD 755.66 million in 2024.
• The Portugal Arthritic Therapeutic market is believed to see growth at a CAGR of 4.3% during the projected period, with a market size of USD 511.90 million in 2024.
• The Greece Arthritic Therapeutic market is believed to see growth at a CAGR of 4.8% during the projected period, with a market size of USD 292.52 million in 2024.
• Rest of Europe's Arthritic Therapeutic market is believed to see growth at a CAGR of 3.2% during the projected period, with a market size of USD 3778.32 million in 2024.

Asia Pacific Arthritic Therapeutic Market

According to Cognitive Market Research, the global Arthritic Therapeutic market size was estimated at USD 81254.2 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 18688.47 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.0% from 2024 to 2031.

• According to Cognitive Market Research, the China Arthritic Therapeutic market size was valued at USD 8409.81 million in 2024 and is believed to grow at a CAGR of 7.5% during the projected period. Arthritic Therapeutic surged in China due to the expansion of innovative remedies and the advancement of clinical trials.
• The Japan Arthritic Therapeutic market is believed to see growth at a CAGR of 6.5% during the projected period, with a market size of USD 2579.01 million in 2024.
• The India Arthritic Therapeutic market had a market share of USD 2242.62 million in 2024 and is believed to grow at a CAGR of 9.8% during the projected period. India's enhancing healthcare infrastructure and increasing healthcare awareness.
• The South Korean Arthritic Therapeutic market is believed to see growth at a CAGR of 7.1% during the projected period, with a market size of USD 1868.85 million in 2024.
• The Australian Arthritic Therapeutic market is believed to see growth at a CAGR of 7.7% during the projected period, with a market size of USD 971.80 million in 2024.
• The South East Asia Arthritic Therapeutic market is believed to see growth at a CAGR of 9.0% during the projected period, with a market size of USD 1289.50 million in 2024.
• The Rest of Asia Pacific Arthritic Therapeutic market is believed to see growth at a CAGR of 7.8% during the projected period, with a market size of USD 1326.88 million in 2024.

South America Arthritic Therapeutic Market

According to Cognitive Market Research, the global Arthritic Therapeutic market size was estimated at USD 81254.2 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 4062.71 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.4% from 2024 to 2031. .

• According to Cognitive Market Research, the Brazil Arthritic Therapeutic market size was valued at USD 1738.84 million in 2024 and is believed to grow at a CAGR of 6.0% during the projected period. Arthritic Therapeutics flourished in Brazil due to increases demand for antirheumatic drugs.
• Argentina's Arthritic Therapeutic market had a market share of USD 682.54 million in 2024 and is believed to grow at a CAGR of 6.3% during the projected period. Argentina's increasing prevalence of arthritis and advancements in treatment options.
• Colombia Arthritic Therapeutic market is believed to see growth at a CAGR of 5.2% during the projected period, with a market size of USD 361.58 million in 2024.
• Peru Arthritic Therapeutic market is believed to see growth at a CAGR of 5.6% during the projected period, with a market size of USD 333.14 million in 2024.
• Chile Arthritic Therapeutic market is believed to see growth at a CAGR of 5.7% during the projected period, with a market size of USD 292.52 million in 2024.
• The Rest of Latin America's Arthritic Therapeutic market is believed to see growth at a CAGR of 4.5% during the projected period, with a market size of USD 654.10 million in 2024.

Middle East and Africa Arthritic Therapeutic Market

According to Cognitive Market Research, the global Arthritic Therapeutic market size was estimated at USD 81254.2 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 1625.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031..

• The GCC Countries Arthritic Therapeutic market is believed to see growth at a CAGR of 6.5% during the projected period, with a market size of USD 695.54 million in 2024. Arthritic Therapeutic sales flourish due to significant investments in healthcare infrastructure.
• The Egypt Arthritic Therapeutic market is believed to see growth at a CAGR of 6.0% during the projected period, with a market size of USD 170.63 million in 2024.
• The South Africa Arthritic Therapeutic market is believed to see growth at a CAGR of 6.7% during the projected period, with a market size of USD 256.76 million in 2024. Arthritic Therapeutic sales flourish in South Africa due to rising prevalence of rheumatoid arthritis and the geriatric population.
• The Turkey Arthritic Therapeutic market is believed to see growth at a CAGR of 5.2% during the projected period, with a market size of USD 139.76 million in 2024.
• The Nigeria Arthritic Therapeutic market is believed to see growth at a CAGR of 4.8% during the projected period, with a market size of USD 170.63 million in 2024.
• The Rest of MEA Arthritic Therapeutic market is believed to see growth at a CAGR of 4.7% during the projected period, with a market size of USD 191.76 million in 2024.

Arthritic Therapeutic Market Analysis

How are Segments Performing in the Global Arthritic Therapeutic Market?

Arthritic Therapeutic Market Product Type Segment Analysis

According to Cognitive Market Research, Non-steroidal Anti-inflammatory Drugs (NSAIDs) stands out as the dominant category over the projected period. This may be linked to the fact that they are widely used for the purpose of relieving pain and having anti-inflammatory properties, which makes them a favored option and generates large income in the pharmaceutical industry.

Biologics emerges as the fastest-growing category in the Arthritic Therapeutic market. Symptom management and disease modification are effectively achieved as a result of the targeted mechanism of action, which specifically targets inflammatory pathways. In addition to the ongoing advancements in biotechnology and personalized medicine, biologics' sustained prominence and anticipated development in the market are a result of their precision in targeting key molecules involved in arthritis pathogenesis.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Arthritic Therapeutic Industry. Request a Free Sample PDF!

Arthritic Therapeutic Market Application Segment Analysis

According to Cognitive Market Research, the dominant category is Rheumatoid Arthritis because of the increasing global prevalence of rheumatoid arthritis. In light of this prevalence, the segment's position is further fortified by the increased demand for innovative and precise treatments. Furthermore, the continuing research and development (R&D) initiatives, which are primarily focused on the development of innovative therapies such as biologics and disease-modifying medicines that are specifically designed for rheumatoid arthritis, are instrumental in maintaining the prominence of this segment within the comprehensive arthritis therapeutics market.

The fastest-growing category in the Arthritic Therapeutic market is Osteoarthritis. This is the result of a combination of factors, such as the increasing prevalence of obesity, the increase in the geriatric population, and the increasing awareness of the early diagnosis and treatment of osteoarthritis. Furthermore, the segment's expansion may be influenced by the increasing number of research initiatives, the development of targeted interventions, and the advancements in understanding the molecular mechanisms of osteoarthritis, as well as the emphasis on enhancing pain management strategies.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Arthritic Therapeutic Distribution Channel Segment Analysis

Arthritic Therapeutic Market Distribution Channel Segment Analysis

According to Cognitive Market Research, the dominant category is Hospital Pharmacies. Given the extensive selection of osteoarthritis therapeutics accessible in these pharmacies and the high volume of patients seeking treatment at hospitals for osteoarthritis. Another significant advantage is the ease with which reimbursements can be claimed for hospital pharmacy purchases.

The fastest-growing category in the Arthritic Therapeutic market is Retail Pharmacies due to the fact that biologics pharmaceuticals are readily available in retail pharmacies and that the number of retail pharmacy outlets is growing all over the world.

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion